Evidence map›Paper›PMID 34044149›Full record

ReviewClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.

Lile Malania, Inge Wagenaar, Onur Karatuna, Arjana Tambic Andrasevic, David Tsereteli, Marine Baidauri, Paata Imnadze, Saskia Nahrgang, Carolien Ruesen

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Enhancing surveillance of foodborne bacteria and antimicrobial resistance using a large centralized laboratory database: Case study of Campylobacter and nontyphoidal Salmonella in Peru.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Lile MalaniaNational Centre for Disease Control and Public Health, Tbilisi, Georgia.
Inge WagenaarCentre for Epidemiology and Surveillance of Infectious Diseases, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Onur KaratunaEUCAST Development Laboratory, Clinical Microbiology, Central Hospital, Växjö, Sweden.
Arjana Tambic AndrasevicUniversity Hospital for Infectious Diseases, Zagreb, University of Zagreb School of Dental Medicine, Zagreb, Croatia.
David TsereteliNational Centre for Disease Control and Public Health, Tbilisi, Georgia.
Marine BaidauriMinistry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia, Georgia.
Paata ImnadzeNational Centre for Disease Control and Public Health, Tbilisi, Georgia.
Saskia NahrgangWHO Regional Office for Europe, Copenhagen, Denmark.
Carolien RuesenCentre for Epidemiology and Surveillance of Infectious Diseases, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: Carolien.Ruesen@rivm.nl.
National Center for Disease Control and Public Health · GENational Institute for Public Health and the Environment · NLUniversity of Zagreb · HRVäxjö Kommun · SEWorld Health Organization Regional Office for Europe · DK

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) is a growing problem worldwide, with an estimated high burden in low- and middle-income countries (LMICs). In these settings, tackling the problem of AMR is often constrained by a lack of reliable surveillance data due to limited use of microbiological diagnostics in clinical practice.

objectivesThe aim of this article is to present an overview of essential elements for setting up an AMR surveillance system in LMICs, to summarize the steps taken to develop such a system in the country of Georgia, and to describe its impact on microbiology laboratories. SOURCES: A literature review of published papers using PubMed and experiences of experts involved in setting up AMR surveillance in Georgia. CONTENT: Basic requirements for implementing a laboratory-based surveillance system in LMICs can be captured under four pillars: (a) governmental support, (b) laboratory capacity and quality management, (c) materials and supplies, and (d) sample collection, data management, analysis and reporting. In Georgia, the World Health Organization Proof-of-Principle project helped to start the collection of AMR surveillance data on a small scale by promoting the use of microbiological diagnostics in clinics, and by providing training and materials for laboratories. Thanks to governmental support and a strong lead by the national reference laboratory, the AMR surveillance network was sustained and expanded after the project ended. IMPLICATIONS: This review describes the Georgian approach in building and expanding a functional AMR surveillance system, considering the elements identified from the literature. The introduction of quality management systems, standardization of guidelines and training paired with targeted capacity building led to improved laboratory standards and management of patients with bloodstream infections. Reliable AMR surveillance data may inform and facilitate policy-making on AMR control. The Georgian experience can guide other countries in the process of building up their national AMR surveillance system.

Indexed as

Clinical Laboratory TechniquesDrug Resistance, BacterialEpidemiological MonitoringAnti-Bacterial AgentsDeveloping CountriesGeorgia (Republic)HumansAnti-Bacterial AgentsAntibiotic resistanceCapacity buildingClinical microbiologyLow- and middle-income countriesSurveillance

Identifiers

PMID34044149
OpenAlexW3165683014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.